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Abstract
Background: It was recently shown that the treatment effect of an antibody can be
described by a consolidated parameter which includes the reaction rates of the
receptor-toxin-antibody kinetics and the relative concentration of reacting species. As
a result, any given value of this parameter determines an associated range of
antibody kinetic properties and its relative concentration in order to achieve a
desirable therapeutic effect. In the current study we generalize the existing kinetic
model by explicitly taking into account the diffusion fluxes of the species.
Results: A refined model of receptor-toxin-antibody (RTA) interaction is studied
numerically. The protective properties of an antibody against a given toxin are
evaluated for a spherical cell placed into a toxin-antibody solution. The selection of
parameters for numerical simulation approximately corresponds to the practically
relevant values reported in the literature with the significant ranges in variation to
allow demonstration of different regimes of intracellular transport.
Conclusions: The proposed refinement of the RTA model may become important
for the consistent evaluation of protective potential of an antibody and for the
estimation of the time period during which the application of this antibody becomes
the most effective. It can be a useful tool for in vitro selection of potential protective
antibodies for progression to in vivo evaluation.
1. Background
The successful bio-medical application of antibodies is well-documented (see [1,2] and
references therein) and there is an ever-increasing interest in the application of antibo-
dies for a mitigation of the effect of toxins associated with various biological threats
(epidemic outbreaks or malicious releases) [3-5]. With the recent progress in bio-
engineering, many antibodies with different affinity parameters have been generated. For
a long time the main target of antibody design has been the antibody affinity. However,
according to recent results [6], affinity, on its own, is a poor predictor of protective or
therapeutic potential of an antibody. In fact, the treatment effect of an antibody can be
described by a consolidated parameter which includes the reaction rates of the receptor-
toxin-antibody kinetics and the relative concentration of reacting species [6]. As a result,
any given value of this parameter determines an associated range of antibody kinetic
properties and its relative concentration in order to achieve a desirable therapeutic
effect. Analytical models, similar to those reported in [6], can be a useful tool for in vitro
selection of potentially protective antibodies for progression to in vivo evaluation. They
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reproduction in any medium, provided the original work is properly cited.can significantly reduce the cost of research and development programs by optimizing
associated experimental efforts. From this perspective, extension and validation of such
models becomes an important goal for biomedical modelling which is partially addressed
in the current study.
There are a number of ways of refining the simple kinetic model for the Receptor-
Toxin-Antibody (RTA) system proposed in [6]. The possibilities include incorporating a
mechanism of receptor recycling, complex pathways for toxin internalization or multiple
receptor population [7]. The focus of our study is on incorporation of the diffusion
effects in the theoretical framework of RTA, i.e. enhancement of the reaction RTA
model [6] with the capability to account for the diffusion fluxes of reacting species [7].
Such enhancement not only enables the application of the RTA model in more realistic
setting (i.e. instead of the simplified “well-mixed” approximation [6] the reaction-diffu-
sive RTA model can describe propagation of toxin into a single cell or into a system of
cells), but also provides a high fidelity estimation of the limiting uptake rate of toxin by
a cell (especially when it is limited by diffusion). More importantly, the refined model
allows consistent simulation of the so-called ‘window of opportunity’ (period of time
after exposure to toxin when the application of an antibody is the most effective). We
believe the two latter parameters (the limiting uptake rate and the ‘window of opportu-
nity’) can become the key parameters in the optimization study for the future antibody
design.
The incorporation of diffusion fluxes into the RTA model can be implemented based
on a generalization of the well-known analytical framework for ligand-receptor binding
[6-10]. From a mathematical point of view, the inclusion of diffusion terms into the
RTA kinetic model leads to significant complications (system of nonlinear PDEs instead
of system of ODEs), which usually prevent any analytical progress and implies numerical
solutions. This was the main motivation for our approach to tackle the refined RTA
model. The aim of this study is to numerically evaluate the protective properties of an
antibody against a given toxin in the model of a spherical cell placed into a toxin-
antibody solution. We consider the problem of the RTA interaction in the most general
setting, when relative concentrations of species are arbitrary and all diffusive fluxes are
taken into account (toxin, antibody and associated complexes). We calculate the anti-
body treatment efficiency parameter under various scenarios and identify the causes of
time variation of this parameter.
We also study the RTA interaction in the ‘Well-Mixed Solution’ (WMS) model, i.e.
when the solution of a toxin, antibody, and toxin-antibody complex is assumed to be
uniformly mixed and homogeneously distributed in an extracellular space. In this case
all diffusion fluxes disappear and the model can be described by Ordinary Differential
Equations (ODE). It is worth noting that, since in such approach receptors are still
confined to the single cell surface, our model is different from the “well-mixed” model
proposed in [6] where all species are homogeneously distributed over the whole space.
But in the case of a low internalization rate (i.e. low toxin inflow into a cell) the
governing equations of these models are of the same type.
The paper is organized as follows. In Section 3 we introduce the reaction-diffusion
model for RTA. The WMS model is presented in Section 4. The results are presented
in Section 5. Conclusions and summarising remarks are presented in Section 6.
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Ω - the extracellular domain, i.e. the problem domain where species diffuse and react
(i.e. toxin, antibody, and toxin-antibody complex),
Se - the external surface of Ω,
Sc - the cell surface (inner surface of Ω),
r0 - the concentration of receptors on the cell surface,
θ(t, x) - the the fraction of bounded receptors,
r0θ - the concentration of the toxin-bound receptors (confined to Sc),
r0(1 - θ) - the concentration of free receptors,
uT, uA, and uC - the concentrations of toxin, antibody, and toxin-antibody complex,
u0
T,u0
A,u0
C- the initial concentrations,
T, A, and C - the diffusivities of the toxin, antibody, and toxin-antibody complex,
k1, k-1 - the forward and reverse constants of toxin-antibody reaction rate,
k2 and k-2 - the forward and reverse constants of toxin and receptor binding rate,
k3 - the rate constant of toxin internalization,
∂n - the outward normal derivative on Se or Sc,
∂t = ∂/∂t,
Δ - the Laplace operator,
ψ(t) - the antibody protection factor (a relative reduction of toxin inside a cell due to
application of antibody).
3. Reaction-Diffusion Model for RTA Interaction
The reaction-diffusion system for the RTA interaction can be derived based on well-
known results of the receptor-ligand system (law of mass action and diffusion). By
including antibody into the system we arrive at the following equations
⎧
⎪ ⎪ ⎪ ⎪ ⎪ ⎨
⎪ ⎪ ⎪ ⎪ ⎪ ⎩
∂tuT = −k1uTuA + k−1uC + κT uT, x ∈  , t > 0,
uT|Se = u0
T, t > 0,
∂nuT =
r0
κT
(−k2(1 − θ)uT + k−2θ), x ∈ Sc, t > 0,
uT|t=0 = u0
T, x ∈  ,
(1)
 
∂tθ = k2(1 − θ)uT − k−2θ − k3θ, x ∈ Sc, t > 0,
θ|t=0 =0 , x ∈ Sc,
(2)
⎧
⎪ ⎪ ⎪ ⎪ ⎨
⎪ ⎪ ⎪ ⎪ ⎩
∂tuA = −k1uTuA + k−1uC + κA uA, x ∈  , t > 0,
uA|Se = u0
A, t > 0,
∂nuA|Sc =0 , t > 0,
uA|t=0 = u0
A, x ∈  ,
(3)
⎧
⎪ ⎪ ⎪ ⎨
⎪ ⎪ ⎪ ⎩
∂tuC = k1uTuA − k−1uC + κC uC, x ∈  , t > 0,
uC|Se =0 , t > 0,
∂nuC|Sc =0 , t > 0,
uC|t=0 =0 , x ∈  .
(4)
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over the time scales of interest (i.e. internalization time, time of toxin depletion etc).
The boundary conditions at the system above correspond to a case where initially the
toxin and antibody are distributed homogeneously in the extracellular domain Ω.T h e
boundary conditions on the outer boundary of the domain are assumed to be the con-
stant concentrations of toxin and antibody and zero concentration of toxin-antibody
complex. It is worth noting that in this case the gradients of uT, uA, uC are nonzero at
the outer surface of the domain and they provide a time-dependent influx of species
into Ω (with implication no conservation law for uT, uA, uC). Indeed, in such an
approach we disregard any depletion of toxin and antibody within Ω (the depletion
will be taken into account in the WNS model, see below). In a practical experiment
this setup can correspond to a single cell embedded into a large volume (compart-
ment) of toxin-antibody solution, so toxin and antibody are in excess. In this context it
is also worth noting that in the real biomedical scenarios the concentration of toxin is
usually very low with respect to the concentration of receptor due to the high concen-
tration of receptors on the surface of living cells and the high toxicological effect
(lethal dose) of the most toxins of interest. This implies that the condition of the
excess of antibody over toxin is practically relevant and are very easy to achieve (e.g.
see experimental results of [11], where the concentration of ricin was about a thousand
times less than the concentration of antibody), while the condition of the excess of
toxin over receptor seems to be infeasible for any in vivo situation (but the latter con-
dition still can be used in lab experiments for the model validation).
It is worth mentioning that models similar to (1)-(4) have been extensively studied in
application to biouptake of pollutants by micro-organisms, cellular nutrition, heteroge-
neous catalysis and analytical instrumental measurements (for comprehensive review of
these studies see [12-17], and references therein). Equations (1)-(4) can be presented in
non-dimensional form by using scales of τ* (time), l (length), and u
*(concentration). By
substituting new variables, x = l¯ x, t = τ∗¯ t, r0 = lu∗¯ r0, uT = u∗¯ uT, uA = u∗¯ uA, uC = u∗¯ uC,
uA0 = u∗¯ u0
A, uA0 = u∗¯ u0
A, ¯ k1 = τ∗u∗k1, ¯ k2 = τ∗u∗k2, ¯ k−1 = τ∗k−1, ¯ k−2 = τ∗k−2, ¯ k3 = τ∗k3,
¯ κA = τ∗κAl−2, ¯ κA = τ∗κAl−2, ¯ κC = τ∗κCl−2 into (1)-(4) we can deduce the same system,
but only in non-dimensional variables. Therefore, for simplicity in what follows, we
treat system (1)-(4) as non-dimensional.
The main parameter of interest is the antibody protection factor (a relative reduction
of toxin attached to a cell due to application of antibody). This parameter can be
defined by the following expression [6]
ψ(t)=
 
Sc θ|u0
A>0dS
 
Sc θ|u0
A=0dS
. (5)
By definition 0 ≤ ψ ≤ 1w i t ht h el o w e rv a l u e so fψ corresponding to the more
profound therapeutic effect of antibody treatment.
By employing (5) it is possible to derive a simple estimation for the saturation value
of parameter ψ (i.e. for the limit t ® ∞). Indeed, from (1)-(4) for the steady-state limit
we can write
θ = θsat =
k2usat
T
k2usat
T + k−2 + k3
=
usat
T
usat
T + K2 + b
, (6)
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T is the saturation concentration of toxin, K2 = k-2/k2, b = k3/k2.T h e n( 5 )
leads to ψ1 = ψ
sat where
ψsat =
θsat|u0
A>0
θsat|u0
A=0
. (7)
So that ψ1 can be expressed in terms of only one ‘bulk’ variable usat
T ≥ 0. Indeed, the
value of ψ
sat can be appreciably affected by the diffusivities of species, since T, A, C
determine the saturation value usat
T by virtue of Eqs. (1)-(4).
4. WMS Model for RTA Interaction
The WMS model corresponds to an assumption that all species (toxin, antibody, and
toxin-antibody complex) are distributed uniformly within the domain Ω. This implies
no spatial gradients of concentrations, so all diffusivity terms disappear from system
(1)-(4). Contrary to (1)-(4) we also assume that there are no fluxes of species across Se,
so we account for depletion of species in the cell compartment Ω (a simple yet consis-
tent approach that accounts for the depletion effect was proposed in [17]). The process
of toxin internalization (i.e. flux of toxin through the cell surface) can be modelled in
t h i sc a s ea sag i v e nr a t eo ft o x i nr e m o v a lf r o mt h ew h o l es y s t e m[ 9 ] .T h e nt h eW M S
model can be translated to a system of ODEs:
  ·
uT = −k1uTuA + k−1uC − k4r0(k2(1 − θ)uT − k−2θ), t > 0,
uT|t=0 = u0
T,
(8)
 
˙ θ = k2(1 − θ)uT − k−2θ − k3θ, t > 0,
θ|t=0 =0 ,
(9)
  ·
uA = −k1uTuA + k−1uC, t > 0,
uA|t=0 = u0
A,
(10)
  ·
uC = k1uTuA − k−1uC, t > 0,
uC|t=0 =0 .
(11)
Here a dot is placed over the variables to represent a time derivative; k4 = Sc/VΩ,
where Sc and VΩ are the area of cell and the extracellular volume. For instance, for a
spherical cell of radius rc, VΩ is a domain between the cell and a concentric sphere of
radius re >rc, V  =
4
3
π(ρ3
e − ρ3
c ), Sc =4 πρ2
c,a n dk4 =3 ρ2
c
 
(ρ3
e − ρ3
c ).F o ras i m p l e
model of cell culture (a uniformly distributed system of cells) the average density of
cell distribution, n, is approximately equal to 3/(4πρ3
e ), so we can treat the ‘external’
scale re as the size of a compartment occupied by an individual cell in the culture.
From this perspective, the dependence of ψ(re) presented below can provide insight
into the dependence of ψ on the cell packing density in the culture since re ≈
[3/(4πn)]
1/3 (see below).
The WMS model (8)-(11) is worth comparing with the model of the RTA interaction
proposed in [6] (a kinetic model of uniformly distributed chemical species and cells).
Despite these models being essentially different in their geometrical setting (in our
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tions become similar in the case when toxin inflow into a cell can be neglected (i.e.
low internalization rate); the latter case seems to be very typical for many practical
situations [7]. The WMS model (8)-(11) being a system of ODEs is much easier to
analyze and solve numerically than the full RTA model (1)-(4) but indeed the WMS
model cannot be used for estimating the effect of diffusivity of species on the protec-
tive properties of antibody (since it contains no diffusivity parameters).
With toxin internalization taken into account, the WMS model has only one conser-
vation law uC + uA = u0
A (internalization implies that toxin is gradually taken away from
the system). However, in the case of the low internalization rate we can set k3 = 0 and
also deduce an “approximate” conservation law for toxin, viz., uT + uC + k4r0θ = u0
T,
which is similar to one used in [6]. These conservation laws significantly simplify an
analytical treatment of the WMS model. For instance, from Eqs. (7) and (8)-(11) it is
possible to derive an approximate analytical expression for the saturation value of pro-
tection factor ψ
sat. Actually, for the steady-state solution of system (8)-(11) without
internalization rate (k3 = 0) it is straightforward to derive the following closed equation
(1 − θ)(u0
T − R0θ −
εu0
Aθ
1+(ε − 1)θ
)=K2θ, (12)
where ε = K2/K1, K1 = k -1/k1, K2 = k -2/k2, R0 = r0k4 (the same equation is given in
[6] for the “well mixed” model). Then the solution of this equation enables the calcula-
tion of protection factor ψ2 = ψ
sat by means of Eq. (7).
We solve Eq. (12) numerically and compare the numerical results with the approxi-
mate analytical predictions deduced from the asymptotic solutions of Eq. (12). Some
asymptotic analysis of Eq. (12) is presented in [6]. Our range of parameters corre-
sponds to the case R0/(εu0
A)   1 and this enables derivation of the approximate
formula
ψsat ≈ ψ3 =
F(u0
A,u0
T)
F(0,u0
T)
, (13)
where F(x,y)=( q1 −
 
q2
1 − 4q2y)/(2q2), q1 = K2 + εx -( ε -2 ) y and q2 = q1 -( εK2 + y).
In order to verify our estimation of ψ near the saturation limit, we also solved non-
steady system (8)-(11) numerically for large time and then by employing formula (7)
determined function ψ4 = ψ
sat. Table 1 shows that for the practically important cases
the expressions for ψ2, ψ3, and ψ4 are in the very good agreement. Table 1 also demon-
strates ψ
sat for the case where internalization rate is taken into account.
Table 1 Comparison of saturation values of ψ for WMS model: ψ
sat = ψ2 (12) and (7),
ψ
sat = ψ3 (13), and ψ
sat = ψ4, where ψ4 is estimated from the solution of (8)-(11) and (7)
at t = 10 000 s
k1 k2 ψ2 ψ3 ψ4
k3 =0 k3 = 0.000033
0.013 0.0125 0.215524 0.215524 0.216026 0.206474
0.013 0.025 0.345686 0.345708 0.345903 0.332632
0.013 0.05 0.508760 0.508754 0.508767 0.493704
0.13 0.0125 0.027219 0.027220 0.027426 0.025913
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We treated system (1)-(4) numerically for the spherically symmetric domain r Î [rc,
re]a n dt > 0 with an implicit finite-difference scheme [18]. These settings constitute
the standard spherical cellular model [8-10,15]. Our selection of the values of para-
meters for the model (1)-(4) was motivated by the values available in the literature
[11,19-22] with the extended range to allow exploration and illustration of the various
transport regimes that are possible in the RTA system. If for some parameters (i.e. dif-
fusivity) data were not available, then we used values from similar models [7-9] and
added some ranges to cater for data uncertainty and to provide sensitivity analysis.
The following values were used in most calculations [7]: u* =6 . 0 2·1 0
13 cm
-3, τ* =1s ,
r0 =1 . 6·1 0
4/Sc,w h e r e1 . 6·1 0
4 is the total number of receptors of the cell, l =1 0
-2
cm, Sc =4 πρ2
c =4 π · 10−6 cm2, ¯ r0 =2 . 1 1 5· 10−3. The values of the other parameters
are given in Table 2. If values of k1, k2, A,a n dT differ from those given in Table 2,
they are specified in the legends of plots. We expect that the chosen values of para-
meters were representative enough to illustrate a rich variety of possible scenarios of
the evolution of the RTA system and provide a reasonable estimate of timescales of
the associated dynamics. The consistent match of the numerical predictions with the
specific experimental results (i.e. on the ricin-neutralising antibodies [11,19-21]) would
involve some additional assumptions about the relationship between the concentration
of species and observable parameters (e.g. cellular viability) and was outside of the
scope of the current paper.
The results of the numerical solutions are presented in Figures 1, 2, 3, 4, 5, 6, 7 and
Tables 1, 3. As we indicated in the Background, the main purpose of our study was to
estimate the effect of diffusive parameters of the species on the protective properties of
an antibody. As such, most plots are presented below to illustrate this effect.
To provide insight into the relation between the diffusion transport and the protec-
tive properties of an antibody in the spherical cellular model, it is convenient to
employ the theoretical framework that is well-established in ecology and electrochem-
istry (toxin uptake by microorganisms and performance of microelectrodes) (e.g., see
[15-17] and references therein). According to [15], the steady-state flux of toxin
towards a spherical cell can be estimated from the following expression
Table 2 Values of parameters used in calculations
Parameter Dimensional value Non-dimensional value
k1 1.3 ·10
5 M
-1 s
-1 1.3 · 10
-2
k2 1.25 ·10
5 M
-1 s
-1 1.25 · 10
-2
k-1 1.4 ·10
-4 s
-1 1.4 · 10
-4
k-2 5.2 ·10
-4 s
-1 5.2 · 10
-4
k3 3.3 ·10
-5 s
-1 3.3 · 10
-5
T 10
-6 cm
2 s
-1 10
-2
A 10
-6 cm
2 s
-1 10
-2
C 10
-6 cm
2 s
-1 10
-2
rc 10
-3 cm 10
-1
re 2·1 0
-3,5·1 0
-3 cm 2, 5
u0
A 6.02 · 10
-13 cm
-3 1
u0
T 3.01 · 10
-13, 6.02 · 10
-14 cm
-3 0.5, 0.1
Skakauskas et al. Theoretical Biology and Medical Modelling 2011, 8:32
http://www.tbiomed.com/content/8/1/32
Page 7 of 15u0
T (14)
where Λ is the conductance of the system (flux-concentration ratio), uT(t) is the con-
centration of toxin on the outer boundary of Ω,v i z .uT(t)= u0
T for the boundary con-
dition of constant concentration or uT(t)=u0
Texp(−t/τd) for the no-flux boundary
condition, * is the effective diffusion of the toxin, τd is the depletion time of toxin in
the bulk, K* = R0/(R0 + K1) [6]. It can be seen that the parameter * and depletion
time τd (if the depletion of toxin is significant) become two ‘aggregated’ parameters
that can be used to comprehensively characterize the influence of an antibody on toxin
transport in the model of spherical cell.
The term * /rc in Eq. (14) represents the diffusive conductance and the term K*k3
represents the internalization conductance [15]. The ratio of the two terms is
Figure 1 Effect of variation of the scale of cell compartment and toxin diffusivity on protection
factor. External radius of the cell compartment re = 2 (1) and re = 5 (2), T =1 0
-2 (solid line), T =1 0
-3
(dashed line), T =1 0
-4 (symbols) and u0
T =0 . 5.
Figure 2 Effect of variation of the scale of cell compartment and toxin diffusivity on protection
factor. External radius of the cell compartment re = 2 (1) and re = 5 (2), T =1 0
-2 (solid line), T =1 0
-3
(dashed line), T =1 0
-4 (symbols) and u0
T =0 . 3.
Skakauskas et al. Theoretical Biology and Medical Modelling 2011, 8:32
http://www.tbiomed.com/content/8/1/32
Page 8 of 15u0
T =0 . 3 (15)
which is called bioavalability number [15] and can be used to characterized the
regime of toxin uptake by the cell [15,16]. If L ≪ 1 the uptake flux is fully controlled
by the internalization process, while in the opposite case L ≫1 it is controlled by diffu-
sion. Note that for the case of ricin competitive binding to cell receptors and the
mono-clonal antibody 2B11 the value of parameter L ≈ 10
-2, i.e. flux is mostly con-
trolled by internalization process. Importantly, even in the case of diffusion dominated
flux the transport of toxin can be characterized by a rich variety of regimes that are
parameterized based on the so-called degree of lability, so these regimes correspond to
the different asymptotical values of parameters *, τd [15-17].
Figure 3 Effect of variation of the scale of cell compartment and toxin diffusivity on protection
factor. External radius of the cell compartment re = 2 (1) and re = 5 (2), T =1 0
-2 (solid line), T =1 0
-3
(dashed line), T =1 0
-4 (symbols) and u0
T =0 . 1.
Figure 4 Effect of the antibody diffusivity on the antibody protection factor. Antibody diffusivity A
=1 0
-1 (1), A =1 0
-2 (2), A =1 0
-3 (3). Horizontal lines correspond to values of ψ
sat given by Eq. (7) for
curves 1 and 2.
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the spherical cellular model is outside the scope of the current paper, so we briefly
present here only some key points that are relevant to the understanding of our
numerical simulations (for details we refer the reader to [15-17]). It can be shown that
the ratio p = * /T is always within the range 1 ≤ p ≤∞with the minimal value p =1
corresponding to the diffusion transport of toxin without presence of antibody (i.e. *
= T ). The latter condition together with Eqs. (14) leads to a simple estimate for the
long-time asymptote of the protection factor of antibody (5)
ψ(t) ≈ ψ∗exp(γt), ψ∗ =
1+L0
1+L0/p
, (16)
where γ =1 / τd − 1/τ0
d ,τ0
d is the depletion time of toxin without antibody, L0 = K*
k3rc/T.
Figure 5 Effect of toxin diffusivity on antibody protection factor. Toxin diffusivity T =1 0
-2 (1), T =5·
10
-3 (2), T =1 0
-3 (3), T =1 0
-4 (4). Horizontal line corresponds to value of ψ
sat given by Eq. (7) for curve 3.
Figure 6 Behavior of antibody protection function determined by WMS model for large time.P l o t s
demonstrate convergence of ψ to saturation limit for different values of parameters k1 and k2 at re =2 ;k1 =
1.3 · 10
-2, k2 : 1.25 · 10
-2 (1), 2.5 · 10
-2 (2), 5 · 10
-2 (3). Horizontal lines correspond to values of ψ
sat given by (13).
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and toxin depletion. We observe that, depending on a value of the parameter g,t h e
asymptotical behavior of the protection factor can be either zero (g <0 ) ,i n f i n i t y( g >
0) or non-zero constant (g = 0). For the diffusion controlled flux, L0 ≫ 1a n dψ* = p
while for the kinetically controlled regime L0 ≪ 1a n dψ* =1 .T h i si m p l i e st h a tb y
changing the diffusivity of the reacting species (i.e. by introducing an antibody) it is
possible (at least in theory) to control the behavior of the protection factor ψ(t). The
case of the constant toxin influx (i.e. no depletion) simply corresponds to g =0 .W e
observed most of these scenarios in our numerical simulations (see below).
An interesting (and not intuitively obvious) result of expression (16) is the general
inequity ψ* ≥ 1 (more precisely 1 ≤ ψ* ≤ 1+L0). This means that for the diffusion-con-
trolled scenario and for the case when toxin depletion is not significant (e.g. for gT ≪
1), the introduction of an antibody can only increase the flux of toxin towards the cell.
This result is a clear manifestation of a possible contribution of the antibody-toxin com-
plex to the total toxin flux, described in [15-17]. Importantly, that for a case of the fast
kinetics (situation when the reaction of antibody-toxin complexation is much faster than
diffusion time of reacting species) the effective diffusivity * is reduced to the mean dif-
fusivity [16,17]
κ∗ =
uTκT + uCκC
uT + uC
, (17)
Figure 7 Behavior of antibody protection function determined by WMS model for large time.P l o t s
demonstrate convergence of ψ to saturation limit for different values of parameters k1 and k2 at re =2 ;k1 =
1.3 · 10
-2, k2 = 1.25 · 10
-2 (1), k1 = 1.3 · 10
-2, k2 = 2.5 · 10
-2 (2), k1 = 1.3 · 10
-1, k2 = 1.25 · 10
-2 (3). Horizontal lines
correspond to values of ψ
sat given by (13).
Table 3 Comparison of saturation values of ψ for model (1)-(4): ψ
sat = ψ1 and ψ
sat = ψ5,
where ψ1 is determined by (6) and (7) with usat
T estimated by (1)-(4) at t = 1000 s, while
ψ5 is determined by (7) with θ
sat estimated by (1)-(4) at t = 10 000 s
T (A =1 0
-2) ψ1 ψ5 A (T =1 0
-3) ψ1 ψ5
10
-2 0.9339 0.9339 10
-1 0.1342 0.1345
5·1 0
-3 0.8433 0.8433 10
-2 0.1480 0.1483
10
-3 0.1480 0.1483 10
-3 0.3729 0.3726
10
-4 0.0047 0.0034 10
-4 0.9801 0.9801
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Page 11 of 15that can be significantly different from the diffusivity of a toxin uT. It is worth noting
that antibody diffusivity does not appear in this expression. The “limit of mean diffu-
sivity” for * g i v e nb y( 1 7 )o c c u r so n l yf o rt h es y s t e mw i t hT ≠ C [16,17] (which is
usually the case because of a difference in molecular weights).
Some analytical models for the calcula t i o no ft h et o x i nd e p l e t i o nt i m e sτ0
d, τd have
been proposed [16]. They are quite involved, and for details, we refer the reader to the
original publications. The results [16] clearly demonstrate that the parameter
γ =1 / τd − 1/τ0
d in (16) can depend on the ‘external’ scale re (i.e. size of the cell ‘com-
partment’) in a quite convoluted way. As was mentioned above, the scale re can be
approximately related to the packing density of cells in a culture (re ≈ [3/(4πn)]
1/3), so
plots ψ(re) can be also interpreted as a simple qualitative illustration of the effect of
variation in packing density n.
The plots ψ(re) in Figures 1, 2, 3 depict the dependence of the antibody protection
factor ψ on the radius of external surface re (i.e. a size of the cell compartment) and
on toxin diffusivity T. We calculated ψ for two values of re (re =2a n dre =5 ) ,f o r
two values of T (T =1 0
-2 and T =1 0
-3), and three values u0
T (u0
T =0 . 5 Figure 1,
u0
T =0 . 3 Figure 2, u0
T =0 . 1 Figure 3).
We believe that the analytical results (16) discussed above and the numerical examples
similar to those presented in Figures 1, 2, 3 may be important for either the planning of
experiments (especially in cell culture) or for the correct interpretation of experimental
data, since they provide a simple estimation for the amplitude of the observable effect
(protection factor) and for the timescale during which this effect can occur (~ 1/g).
The results depicted in Figures 1, 2, 3 also provide an illustrative example of the
main finding of our study: the time evolution of the protection factor ψ(t) may switch
from monotonic to markedly non-monotonic behavior with a variation of diffusion
parameters of the RTA model. This phenomenon is in line with the theoretical frame-
work proposed in [15-17]) and was observed frequently in our simulations.
Following the well-established application of the concept of lability to the spherical
cell model [15-17], an incorporation of diffusion effects into our model enabled the
simulation of a new phenomenology, which may occur in the RTA system. For
instance, with system (1)-(4) we were able to model competitive behavior of the reac-
tion and diffusion fluxes. As was mentioned above, the latter often manifests itself in
rather convoluted (non-monotonic) dependence of concentration of species and their
diffusion coefficients, see Figures 4 and 5. The plots in Figures 4 and 5 depict a variety
of scenarios for time evolution of ψ for the different diffusivity of toxin and antibody
(other parameters were the same). We can clearly see a switch from monotonic to
non-monotonic behavior as we decrease diffusivity of toxin T (Figure 5). The cases of
non-monotonic behavior with a profound minimum of ψ(t) provide revealing examples
of the practically important concept of a ‘window of opportunity’ discussed in the
Background. Once the function ψ(t) moves far away from its minimal value, the ‘block-
ing’ effect of an antibody markedly decreases. We observe that the ‘window of oppor-
tunity’ is very scenario-dependent and it can be easily estimated from the plots similar
to those presented in Figure 5.
The plots presented in Figures 1, 2, 3, 4, 5 illustrate detailed insights into the trans-
port process associated with the different behavior of the protective function ψ(t)
Skakauskas et al. Theoretical Biology and Medical Modelling 2011, 8:32
http://www.tbiomed.com/content/8/1/32
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see that the non-monotonic behavior is caused by the non-monotonic supply (trans-
port) of toxin across the compartment to the cell surface; this transport can be affected
by changing the diffusivity of species. The main conclusion from our numerical results
is that the relative diffusivity of species can be used to control the effect of antibody
treatment during a short time after the exposure to a toxin (usually a few minutes).
The plots presented in Figures 6 and 7 show the dependence of ψ on k1 and k2 for
the WMS model and demonstrate a possible switch of ψ from monotonic to non-
monotonic behavior as k2 grows. Calculations show that ψ(t) depends very weakly on
re and this an indication that the reactions in the surface layers around the cell (diffu-
sive and reaction) provide the dominant contribution to the transport properties of the
system. This result is depicted in Figures 6 and 7 where all curves are given for re =2
and re = 5. As time increases, function ψ(t) tends to the diffusivity-dependent asymp-
tote ψ
sat = ψ1 for system (1)-(4) and to the reaction-dependent asymptote ψ
sat = ψ3 for
the WMS model irrespective of its short-time behavior (which is indeed controlled by
(16)). The diffusive dependency of the saturation limit of the system (1)-(4) becomes
evident if we recall that at the steady state, the flux of internalized toxin (i.e. flux
across Sc) should be compensated by the diffusion influx across the outer surface Se.I n
order to validate this asymptotic behavior we computed a rich set of scenarios. These
results are presented in Figures 4, 5, 6, 7 and in Tables 1 and 3. In Table 3 we com-
pare ψ1 and ψ5 where ψ1 is determined by (6) and (7) with usat
T estimated by (1)-(4) at
t =1 0 0 0s ,w h i l eψ5 is determined by (7) with θ
sat estimated (1)-(4) at t =1 00 0 0s .
We observe that function ψ(t) converges to an asymptotic value, but this convergence
can be rather slow.
As was suggested by one of the anonymous referees, the observable strongly non-
monotonic behavior of parameter ψ(t) in some of our modeling scenarios can possibly
be explained by applying the concept of dynamic speciation to the formation of a toxin-
antibody complex [15-17]). In the diffusion-controlled regime the dynamic speciation
(i.e. the fast toxin-antibody kinetics over diffusion time) can lead to the significant con-
tribution to the toxin flux towards the cell and (under condition C <T) can even cause
a ‘retardation’ effect [15]. After some estimations we found this hypothesis quite reason-
able. For a cell size of rc ≈ 10
-5 mt h ed i f f u s i o nt i m ei sτ ≈ 0.2 s for  ≈ 1 · 10
-9 m
2s
-1.
The estimation for equilibration time τe was derived from the rigorous theoretical frame-
work proposed in [23] for competitive binding system (application of this framework to
the toxin-receptor and toxin-antibody binding can be found in [6]). Indeed the equilibra-
tion time τe is a strong function of the toxin concentration; it rapidly decreases as the
toxin concentration increases (reacting species can faster find each other to form a com-
plex). If as a reference point we assume that the value of parameters correspond to the
scenario of binding of ricin to receptor and to the antibody then for the toxin concentra-
tion T = 10 pM the reaction time is of order of 10 s. By further increasing the toxin con-
centration (five times in our simulations) it appears that we approach the transition
threshold from the ‘inert’ to the ‘dynamic’ complex, so the toxin-antibody complex starts
contributing to the diffusion flux. A more challenging task was to identify the scenarios
where this additional contribution can be appreciable, since the total flux is mainly inter-
nalization-controlled. Nevertheless, if we recall that diffusivities and concentration of
species are varied by an order of hundreds, then reaching the diffusion-controlled
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Page 13 of 15regime in some of our simulations looks quite feasible. A more detailed interpretation of
our numerical results with the concept of dynamic speciation would require additional
numerical calculations (careful estimations of equilibration time of complex for each
scenario) and is outside of the scope of the current study.
6. Concluding Remarks
In summary, we have refined the RTA model developed in [6] by incorporating diffusion
of reacting species in the extracellular space. By solving numerically the system of non-
linear PDEs of the model we managed to simulate a rich variety of reaction-diffusion
processes that may occur in the RTA system. For various combinations of parameters
(rates of reactions, diffusivity and initial concentrations) we estimated the effect of anti-
body on the toxin penetration into a cell and expressed the effect of the antibody treat-
ment in terms of a non-dimensional protection factor (relative reduction of toxin
concentration within a cell). We demonstrated that this factor can be a significantly
non-monotonic function of time and its behavior depends on an interplay between diffu-
sive and reaction processes in the RTA model. We also examined the time evolution of
the protection factor and found that it eventually tends to a diffusivity-dependent
asymptotic limit, but the convergence to this asymptote may take significant time. From
this perspective, the refinement of the RTA model proposed in the present study
becomes important for the consistent evaluation of protective potential of an antibody
and for the estimation of the time period during which the application of this antibody
becomes the most effective.
T h es e l e c t i o no ft h er a t ec o n s t a n t sf o rn u m erical simulations was motivated by data
reported in the literature [11,19-22], with the significant ranges of variability to provide a
simple sensitivity analysis for the system under consideration. The values for other con-
stants (i.e. diffusivity) were selected based on similarity with other models [8-10]. The cho-
sen values of parameters enable an illustrative demonstration of a rich variety of regimes
of the evolution that could occur in the RTA system. These regimes are similar to ones
occurring in electrochemistry and ecological studies (performance of microelectrodes and
toxin uptake by microorganisms). Further validation of the proposed model with a parti-
cular set of experimental data on toxin-neutralising antibodies (e.g. [11,21]) would require
a separate study. Such a study would include an application of a data fitting algorithm that
accounts for the experimental data uncertainty as well as some additional assumptions
about relationships of the model predictions (concentration of species, protection factor)
with the observable quantities (i.e. cellular viability). The latter assumptions may signifi-
cantly affect the experimental data fit and the evaluation of predictive skills of the pro-
posed model. We will report on such study in a separate publication.
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